Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
18.47
-0.07 (-0.38%)
At close: Mar 18, 2026, 4:00 PM EDT
18.00
-0.47 (-2.54%)
After-hours: Mar 18, 2026, 5:27 PM EDT
Caris Life Sciences Market Cap
Caris Life Sciences has a market cap or net worth of $5.22 billion as of March 18, 2026.
Market Cap
5.22B
Enterprise Value
4.85B
1-Year Change
n/a
Ranking
Category
Stock Price
$18.47
Market Cap Chart
Since the IPO on June 18, 2025, Caris Life Sciences's market cap has decreased from $5.95B to $5.22B, a decrease of -12.37%. That is a compound annual growth rate of -16.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 5.24B | -31.18% |
| Dec 31, 2025 | 7.61B | 27.84% |
| Jun 18, 2025 | 5.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 6.18B |
| Rhythm Pharmaceuticals | 6.17B |
| Cogent Biosciences | 5.78B |
| Mirum Pharmaceuticals | 5.60B |
| CG Oncology | 5.56B |
| PTC Therapeutics | 5.55B |
| Celcuity | 5.32B |
| Xenon Pharmaceuticals | 5.21B |